Records 1 - 20 (of 20 Records)
|Query Trace: Microsatellite Instability and CD4[original query]|
| Immune profiling of microsatellite instability-high and polymerase ? (POLE)-mutated metastatic colorectal tumors identifies predictors of response to anti-PD-1 therapy.
Journal of gastrointestinal oncology 2018 7 9 (3): 404-415.
Wang Chongkai, Gong Jun, Tu Travis Y, Lee Peter P, Fakih Marw
| Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.
Bioscience reports 2020 4 40 (4): .
Lv Jia, Zhu Yongze, Ji Alin, Zhang Qi, Liao Guodo
| Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis.
Frontiers in molecular biosciences 2020 11 7 569414.
Song Jukun, Han Jing, Liu Feng, Chen Xianlin, Qian Shenqi, Wang Yadong, Jia Zhenyu, Duan Xiaofeng, Zhang Xiangyan, Zhu Jiang
| Genetic Variants in the Regulatory T cell-Related Pathway and Colorectal Cancer Prognosis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 10 29 (12): 2719-2728.
Neumeyer Sonja, Hua Xinwei, Seibold Petra, Jansen Lina, Benner Axel, Burwinkel Barbara, Halama Niels, Berndt Sonja I, Phipps Amanda I, Sakoda Lori C, Schoen Robert E, Slattery Martha L, Chan Andrew T, Gala Manish, Joshi Amit D, Ogino Shuji, Song Mingyang, Herpel Esther, Bläker Hendrik, Kloor Matthias, Scherer Dominique, Ulrich Alexis, Ulrich Cornelia M, Win Aung K, Figueiredo Jane C, Hopper John L, Macrae Finlay, Milne Roger L, Giles Graham G, Buchanan Daniel D, Peters Ulrike, Hoffmeister Michael, Brenner Hermann, Newcomb Polly A, Chang-Claude Jen
| Prognostic value and immunological role of PDCD1 gene in pan-cancer.
International immunopharmacology 2020 Oct 89 (Pt B): 107080.
Miao Yandong, Wang Jiangtao, Li Qiutian, Quan Wuxia, Wang Yingying, Li Chen, Wu Jingjing, Mi Dengh
| Association of CSMD1 with Tumor Mutation Burden and Other Clinical Outcomes in Gastric Cancer.
International journal of general medicine 2021 11 14 8293-8299.
Wang Xuning, Wang Shixiang, Han Yalin, Xu Maolin, Li Peng, Ke Mu, Teng Zhipeng, Huang Pu, Diao Ziyan, Yan Yongfeng, Meng Qingyu, Kuang Yanshen, Zheng Wei, Liu Hongyi, Liu Xuesong, Jia Baoqi
| Distinct mutational profile and immune microenvironment in microsatellite-unstable and POLE-mutated tumors.
Journal for immunotherapy of cancer 2021 10 9 (10): .
Hwang Hee Sang, Kim Deokhoon, Choi Je
| Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer.
Frontiers in immunology 2021 10 12 722807.
Shi Junhong, Bao Meiyu, Wang Weifeng, Wu Xuan, Li Yueying, Zhao Changdong, Liu Weiw
| Differential Expression of the TLR4 Gene in Pan-Cancer and Its Related Mechanism.
Frontiers in cell and developmental biology 2021 10 9 700661.
Hu Jialing, Xu Jiasheng, Feng Xiaojin, Li Yiran, Hua Fuzhou, Xu Guoh
| Comprehensive Multiomics Analysis Identified IQGAP3 as a Potential Prognostic Marker in Pan-Cancer.
Disease markers 2022 9 2022 4822964.
Wang Guoqing, Zhou Xiao, Li Yuanyuan, Zhao Min, Zou Yiming, Lu Qicheng, Wu Yuga
| Identification and validation of a tumor mutation burden-related signature combined with immune microenvironment infiltration in adrenocortical carcinoma.
Mathematical biosciences and engineering : MBE 2022 May 19 (7): 7055-7075.
Luo Yong, Chen Qingbiao, Lin Jing
| Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types.
Frontiers in molecular biosciences 2022 4 9 743515.
Wu Yuliang, Huang Wei, Xie Yutong, Wang Chunyan, Luo Ning, Chen Yingying, Wang Liefu, Cheng Zhongping, Gao Zhengliang, Liu Shupe
| Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma.
BMC medicine 2022 4 20 (1): 133.
Wang Zhenghang, Wang Xinyu, Xu Yu, Li Jian, Zhang Xiaotian, Peng Zhi, Hu Yajie, Zhao Xinya, Dong Kun, Zhang Bei, Gao Chan, Zhao Xiaochen, Chen Hui, Cai Jinping, Bai Yuezong, Sun Yu, Shen L
| FAM46C as a Potential Marker for Pan-Cancer Prognosis and Predicting Immunotherapeutic Efficacy.
Frontiers in genetics 2022 2 13 810252.
Deng Jiehua, Xiao Wei, Wang Zhe
| Mutation of MUC16 Is Associated With Tumor Mutational Burden and Lymph Node Metastasis in Patients With Gastric Cancer.
Frontiers in medicine 2022 9 836892.
Zhang Fengxiang, Li Xianzhe, Chen Huaxian, Guo Jianping, Xiong Zhizhong, Yin Shi, Jin Longyang, Chen Xijie, Luo Dandong, Tang Haijie, Mao Chaobin, Lian L
| System Analysis of Adaptor-Related Protein Complex 1 Subunit Mu 2 (AP1M2) on Malignant Tumors: A Pan-Cancer Analysis.
Journal of oncology 2022 2 2022 7945077.
Yi Yuanxue, Zhang Qiufang, Shen Youfeng, Gao Yueyi, Fan Xiaohong, Chen Sini, Ye Xin, Xu Ji
| The role of YAP1 in survival prediction, immune modulation, and drug response: A pan-cancer perspective.
Frontiers in immunology 2022 12 13 1012173.
Hu Xueqing, Zhang Yingru, Yu Hao, Zhao Yiyang, Sun Xiaoting, Li Qi, Wang Y
| Interaction between glycolysis?cholesterol synthesis axis and tumor microenvironment reveal that gamma-glutamyl hydrolase suppresses glycolysis in colon cancer.
Frontiers in immunology 2022 12 13 979521.
Chen Yan-Jie, Guo Xi, Liu Meng-Ling, Yu Yi-Yi, Cui Yue-Hong, Shen Xi-Zhong, Liu Tian-Shu, Liang
| Upregulation of HCFC1 expression promoted hepatocellular carcinoma progression through inhibiting cell cycle arrest and correlated with immune infiltration.
Journal of Cancer 2023 6 14 (8): 1381-1397.
Huaxiang Wang, Meng Yu, Chengkai Yang, Qingsong
| The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
Gynecologic oncology 2023 6 175 133-141.
Jin Li, Xiaohong Xue, Yan Zhang, Fengna Ding, Wenyan Wu, Cuicui Liu, Yang Xu, Hanlin Chen, Qiuxiang Ou, Yang Shao, Xinjun Li, Fei Wu, Xiaohua